BridgeMD
Sentinel lymph node biopsy in patients with parotid gland carcinoma using a combination of 99mTc-nanocolloid and 68Ga-tilmanocept PET/CT: A feasibility study. (SNparotis)
EU CTIS ID: 2024-514233-37-00
What this study is testing
To evaluate the feasibility and prove the concept of sentinel lymph node biopsy (SLNB) in patients with carcinoma of the parotid gland and scheduled for parotidectomy and elective neck dissection.
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- 1.The patient has provided written informed consent authorization before participating in the study. 2. The patient has a diagnosis of primary carcinoma of the parotid gland, and is stage T1-T4, cN0, M0 (see Appendix 3: TNM staging AJCC UICC 8th edition). 3. Clinical nodal staging (cN0) has been confirmed by negative results from CT, MRI, PET/CT and/or ultrasound-guided fine needle aspiration cytology within 30 days of the SLNB procedure. 4. The patient is a candidate for parotidectomy and elective (selective or modified radical) neck dissection. 5. The patient is ≥18 years of age at the time of consent. 6. The patient has an ECOG status of Grade 0 – 2 (see Appendix 4: ECOG Performance Status Grading)
You likely can't join if
- 1. The patient is incapacitated. 2. The patient has had a previous allergic reaction after administration of a radionuclide tracer. 3. The patient has clinical or radiological evidence of metastatic cancer to the regional lymph nodes. 4. The patient has a history of neck dissection, or gross injury to the neck that would preclude reasonable surgical dissection for this trial, or radiotherapy to the neck. 5. The patient is actively receiving systemic cytotoxic chemotherapy. 6.The patient is on immunosuppressive, anti-monocyte, or immunomodulatory therapy.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.